Essential thrombocytosis natural history, complications and prognosis

Essential thrombocytosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Epidemiology and Demographics
Risk Factors
Screening
Causes
Differentiating Essential thrombocytosis from other Diseases
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Essential thrombocytosis natural history, complications and prognosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Essential thrombocytosis natural history, complications and prognosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Essential thrombocytosis natural history, complications and prognosis
CDC on Essential thrombocytosis natural history, complications and prognosis
Essential thrombocytosis natural history, complications and prognosis in the news
Blogs on Essential thrombocytosis natural history, complications and prognosis
Directions to Hospitals Treating Essential thrombocytosis
Risk calculators and risk factors for Essential thrombocytosis natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Essential thrombocytosis is associated with a good prognosis if patients are medically supervised on a regular basis. Lifespan is usually normal as any other unaffected person, though some patients may have symptoms from vascular occlusion and/or bleeding. Rarely the disease may undergo a leukemic conversion or myelofibrosis.

Prognosis

• Essential thrombocytosis is associated with a good prognosis if medically supervised on a regular basis.
• Most of the patients remain asymptomatic for most of their life and are diagnosed on routine blood tests. Although some patients with very high counts may present with severe hemorrhagic or thombotic events needing treatment.
• Rarely the disease may progress to acute leukemia or myelofibrosis.

References

Template:WikiDoc Sources